He also pays attention to the underlying mechanisms of TCM in treating CKD, such as exploring the molecular mechanisms of TCM compounds in treating diabetic nephropathy based on network pharmacology (48), and investigating the therapeutic mechanisms of TCM in gouty nephropathy via the NF-κB signaling pathway (49). The gene discussed is NFKB1; the disease is chronic kidney disease.